Where is NeuroSync located?

NeuroSync is headquartered in Washington, DC, United States.

How many employees does NeuroSync have?

As of Mar 31, 2026, the latest employee count at NeuroSync is 35.

Is NeuroSync a funded company?

NeuroSync is a funded company, having raised a total of $7.43M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 04, 2017.

When was the latest funding round of NeuroSync?

NeuroSync's latest funding was a $***** Series A round on Jan 10, 2018, with participation from 1 investor.

Where does NeuroSync rank among its competitors?

NeuroSync ranks 7th amongst 135 active competitors, of which 35 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was neuroClues, which secured $11.6M in Apr, 2026.

Who are the top competitors of NeuroSync?

NeuroSync's top competitors include Holmusk, Neuralight and neuroClues. Among them, neuroClues secured the most recent funding round in April, 2026.

NeuroSync - 2026 Company Profile, Funding & Competitors

NeuroSync is a series A company based in Washington, DC (United States). It operates as a Provider of AI-based platform to assess brain health, deliver therapy, and optimize performance. NeuroSync has raised $7.43M in funding from Quadrant. The company has 135 active competitors, including 35 funded and 4 that have exited. Its top competitors include companies like Holmusk, Neuralight and neuroClues.

Company Details

Website: neurosync.health
Social

Key Metrics

Location

Washington, DC, United States

Stage

Series A

Total Funding

$7.43M in 3 rounds

Latest Funding Round

Series A, Jan 10, 2018, $*****

Investors

Quadrant & 5 more

Ranked

7^th among 135 active competitors

Employee Count

35 as on Mar 31, 2026

Similar Companies

Innovaccer & 2441 more

View NeuroSync's full profile

NeuroSync has raised a total funding of $7.43M over 3 rounds. Its first funding round was on Apr 04, 2017. Its latest funding round was a Series A round on Jan 10, 2018 for $*****. 1 investor participated in its latest round. NeuroSync has 6 institutional investors.

Here is the list of recent funding rounds of NeuroSync:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 10, 2018	9580959	Series A	5548450	2913389	3106946	2678022
Sep 07, 2017	4364086	Seed	8046188	3919783	8960758	4252237
Apr 04, 2017	7495997	Grant (prize money)	9291436	1572516	6273173	MassChallenge

Access funding benchmarks and valuations. Sign up today!

View details of NeuroSync's funding rounds and investors

NeuroSync's employee count trend

NeuroSync has 35 employees as of Mar 26. Here is NeuroSync's employee count trend over the years:

Uncover NeuroSync's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroSync include Holmusk, Neuralight and neuroClues. Here is the list of Top 10 competitors of NeuroSync, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Holmusk 2015, Singapore (Singapore), Acquired	AI based digital health solutions and data analytics for providers	$109M	Optum Ventures, OCTAVE Capital & 37 others	69/100
2nd	Neuralight 2021, San Francisco (United States), Series A	AI-based neurological evaluation and assessment tool for diagonosis	$30.5M	Koch Disruptive Technologies, Breyer Capital ... & 17 others	60/100
3rd	neuroClues 2020, Louvain-la-neuve (Belgium), Series A	Provider of eye-tracking devices for healthcare practitioners	$21.8M	Graph Ventures, Europa & 11 others	55/100
4th	NovaSight 2016, Lod (Israel), Series B	Provider of eye-tracking-based solutions for vision assessment and treatment	$20M	Rimonci, EIT Health	51/100
5th	Neurotrack 2012, Redwood City (United States), Series C	Provider of clinical assessment tool to diagnose neurological disorders	$57.8M	Khosla Ventures, Sozo Ventures & 17 others	50/100
6th	Rebion 2009, Boston (United States), Seed	Provider vision scanning devices to diagnose brain diseases	$7.46M	NIH, MassChallenge & 2 others	50/100
7th	NeuroSync Washington, DC (United States), Series A	Provider of AI-based platform to assess brain health, deliver therapy, and optimize performance	$7.43M	Oceanic Partners, MassChallenge & 4 others	47/100
8th	EyeControl 2014, Tel Aviv (Israel), Series A	Eye controled communication device solution for ALS patients	$7.5M	Connecticut Innovations, Menomadin Foundation ... & 13 others	47/100
9th	Tobii Dynavox 1983, Danderyd (Sweden), Public	Provider of assistive communication solution for differently abled people via eye-tracking	-	Vestar Capital Partners	46/100
10th	C. Light Technologies 2014, Berkeley (United States), Seed	Developer of eye-tracking solution provider to detect and monitor neurodegenerative diseases	$3.25M	Creative Ventures, Alzheimer's Drug Discovery ... & 10 others	46/100